This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Surowiec, S. M. Articles by Davies, M. G. Search for Related Content PubMed PubMed Citation Articles by Surowiec, S. M. Articles by Davies, M. G. Social Bookmarking                         What's this?

Endovascular Management of Central Venous Stenoses in the Hemodialysis Patient: Results of Percutaneous Therapy

Allison J. Fegley, MD

William J. Tanski, MD

Nayan Sivamurthy, MD

Karl A. Illig, MD

David E. Lee, MD

Rochester, NY

David L. Waldman, MD

Center For Vascular Disease, Interventional Radiology, University of Rochester Medical Center, Rochester, NY

Richard M. Green, MD

Rochester, NY

Mark G. Davies, MD, PhD

University of Rochester Medical Center, 601 Elmwood Ave Box 652, Rochester, NY 14642 mark_davies{at}urmc.rochester.edu

The purpose of this study was to determine the functional results of transvenous angioplasty for the treatment of central venous stenoses in patients with failing upper extremity arteriovenous access. Two hundred consecutive patients presented with threatened arteriovenous access from January 1999 through July 2002. Angiographic evidence of central venous stenosis was present in 35 patients (18%) (superior vena cava 5, brachiocephalic veins 14, and subclavian veins 18). Follow-up averaged 873 days from the date of initial intervention. The initial technical success rate was 89%. Primary patency for each intervention was 85% at 30 days, 55% at 6 months, 43% at 1 year, and 0% at 2 years. Assisted primary patency rates were 88% at 30 days, 80% at 1 year, and 64% at 2 years. Freedom from central venous dialysis catheter placement was 82% at 30 days, 63% at 3 months, 51% at 1 year, 37% at 2 years, and 25% at 3 years. Freedom from a dialysis catheter was superior in those patients with autogenous arteriovenous fistulas. Transvenous angioplasty appears to be beneficial for hemodialysis patients with central venous stenoses, and it helps preserve functional access in the affected extremity, particularly in patients with autogenous fistulas.

Vascular and Endovascular Surgery, Vol. 38, No. 4, 349-354 (2004)
DOI: 10.1177/153857440403800407


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				U. Ozyer, A. Harman, E. Yildirim, C. Aytekin, F. Karakayali, and F. Boyvat Long-Term Results of Angioplasty and Stent Placement for Treatment of Central Venous Obstruction in 126 Hemodialysis Patients: A 10-Year Single-Center Experience Am. J. Roentgenol., December 1, 2009; 193(6): 1672 - 1679. [Abstract] [Full Text] [PDF]